DRUG · Mapped RxNorm record
Abiraterone acetate
Normalized identity: abiraterone acetateView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
NCT01517802
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Prednisone
Normalized identity: prednisoneView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Metastatic Breast Cancerunresolved
Interventions
Abiraterone acetateDRUG · verified · RxNorm: abiraterone acetate
PrednisoneDRUG · verified · RxNorm: prednisone
Sponsors & collaborators
Janssen Research & Development, LLClead sponsor
Mapped research locations
New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1DallasTexas, United States1BarcelonaSpain1AuroraColorado, United States1OmahaNebraska, United States1HamburgGermany1ChattanoogaTennessee, United States1UppsalaSweden1AntwerpBelgium1Newcastle upon TyneUnited Kingdom1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01517802 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.